Clinical Trial Update: The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil [EARLY_Phase 1]

View source ↗

Summary

This completed early Phase 1 trial evaluated changes in cognitive function after 12 weeks of donepezil treatment in individuals with Alzheimer's disease. Cognit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: AstraZeneca | Conditions: Alzheimer's Disease | EARLY_Phase 1 | Status: COMPLETED